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Background
Over the last few decades, several studies have shown
that plants can be a viable option for producing func-
tional recombinant proteins with a wide range of struc-
tural characteristics [1]. In addition, the potential benefit
for developing countries is a prominent feature that we
have recently addressed [2]. Plant-produced recombinant
proteins can already be considered a novel component in
sustainable food production [3]. A major reason for this
optimism relates to cost. Indeed, it is widely recognized
that plants used as bioreactors to produce recombinant
proteins would enable a significant reduction in overall
manufacturing costs [2]. Although recombinant proteins
can be functionally expressed in different plant systems,
it is imperative to determine the platform that offers the
most advantageous conditions for the expression and
recovery of a particular protein [1]. In addition, because
plant pathogenic organisms cannot cause human disease,
this opens the possibility of exploiting plants and edible
fruits as potential candidates for the production of orally
administered antigens [1]. Basically, there are three stra-
tegies for recombinant protein production in plant-based
systems: (1) use of cell-culture-based systems that are
equivalent to mammalian, microbial and insect cell sys-
tems; (2) transient expression of foreign genes in plant
tissues that are transformed by either agroinjection or by
viral infection and (3) development of transgenic plants
carrying stably integrated transgenes [4,5]. Here, I will
focus on some of our recent results on transient expres-
sion and soybean seed as bioreactor-based systems. Tran-
sient expression systems are very useful for research and
are now being routinely used for the rapid production of
valuable proteins. These systems allow high throughput
production and straightforward manipulation, permitting
the rapid validation of expression constructs and the
production of large amounts of recombinant protein
within a few weeks. As a direct consequence, the protein
yields from transient expression in plants are normally
higher than yields observed in other recombinant plant
systems. Transient technology is based on the insertion
of transgenes into plant cells using plant viruses, com-
monly the tobacco mosaic virus (TMV) and the potato
virus × (PVX) as well as transgenic Agrobacterium tume-
faciens. Transgene insertion occurs without stable chro-
mosomal integration, resulting in non-permanent and
non-inheritable gene expression. Because the transfer
rates of Agrobacterium T-DNA and viral-carried genes
can reach a very high number of plant cells after infec-
tion. Tobacco leaves are the dominant choice for the
development of commercial platforms using transient
expression [1]. Seeds as bioreactors also provide a poten-
tial economical platform for the large-scale production
and storage of recombinant proteins [1,5]. Soybean seed
storage proteins are of great interest for the development
of regulated tissue-specific genes products of commercial
interest through recombinant DNA technology. The 7S
globulins are comprised of b-conglycinin subunits.
b-conglycinin regulatory sequences are seed tissue-specific,
temporally regulated and expressed in both the embryonic
axis and cotyledons of developing seeds.
Methods
For transient expression, different constructs were tested
containing signal peptides for endosplasmic reticulum
(ER), apoplast and chloroplast. To generate transgenic
soybean lines, coding sequences of the human growth
hormone; human coagulation factor IX, NY-ESO-1 and
cyanovirin (CV-N) genes were placed under control of
different seed-specific promoters and signal peptides.
Utilizing biolistic-mediated transformation (Rech et al.,
2008), each construct was introduced into the soybean
genome and putative transgenic plants were obtained
[5]. The utilization of a nano-UPLC fractionation and
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SynaptHigh Definition Mass Spectrometry (HDMS)
allowed us to develop a nanoESI positive mode system
to conduct a characterization of the recombinant pro-
teins in a single seed with Identity [6].
Results and conclusions
Transient expression of cancer/testis NY-ESO-1 antigen
was detected in Nicotiana benthamiana leaves using a
PVX-based transient assay. Accumulation in leaf tissue
was influenced by the subcellular localization. No signal
was detected when the NY-ESO-1 antigen was targeted
to chloroplast or to the apoplast, and detection was only
possible when the protein was targeted to the ER.
NanoUPLC-MSE analysis confirmed the presence of het-
erologous NY-ESO-1 at a level of approximately 0.1% of
the total soluble protein extract (TSP). Exploiting the uti-
lization of seed-specific regulatory sequences was possi-
ble to direct and accumulate recombinant proteins in the
PSV’s from soybean seeds [5]. Expression levels of bioac-
tive human growth hormone (hGH) and human coagula-
tion factor IX (and hFIX) were respectively of up to 2.9%
TSP content (corresponding to approximately 9 g kg-1)
and up to 0.23% (0.8 g Kg-1). NY-ESO-1 antigen pre-
sented low expression level in soybean seeds (<0,1%
TSP). The somatogenic activity bioassay demonstrated
that the hGH expressed in soybean seeds is fully active.
Protein extracts from transgenic seeds containing the
hFIX showed a blood-clotting activity of up to 1.4% of
normal plasma. Anti-HIV assays from semi-purified
SOY-CV-N, indicated an effective anti-HIV activity in
the viral assay. Purification of pure recombinant CV-N in
soybean seeds is still ongoing, showing a high affinity for
CV-N to bind to glycinin and B-conglycinin proteins
from seeds. NanoUPLC-MSe analytical results indicated
expression level and correct structural characterization of
recombinant protein sequences. Ultrastructural immuno-
cytochemistry assays revealed that the recombinant
proteins accumulated in the endoplasmic reticulum
(ER)-derived protein storage vacuoles. Recombinant
molecules were visualized all along the cistern lumen
but were absent from the interior of seed oil bodies.
Currently, we are concentrating efforts on studies and
development of technologies for genome editing and
engineering using TALEN, CRISPR, synthetic chromo-
somes and super-enhancers [7-9]. This should contribute
to: a) understanding the minimum number of bioparts
necessary for metabolic function and regulation of gene
expression; b) developing synthetic chromosomes, which
may enable the accurate expression of gene families;
c) developing regulatory circuits and designing synthetic
genes that can be based on standard biological parts, as
models for the development of synthetic biology tools for
engineering genomes. In addition, making use of geno-
mics as a template founded on molecular synthesis and
assembly, using recombinant DNA technology and syn-
thetic biology, has allowed the sustainable prospection
and manipulation of innovative traits found in biodiver-
sity [10]. The aim includes improvement and develop-
ment of novel tools for production of recombinant
proteins in plant systems.
Acknowledgements
This study was supported in part by the National Council for Scientific and
Technological Development (CNPq), Foundation Coordination for the
Improvement of Higher Education Personnel (CAPES), Fundação de Apoio a
Pesquisa (FAP-DF) and Embrapa Genetic Resources and Biotechnology.
Authors’ details
1Embrapa Genetic Resources and Biotechnology, Parque Estação Biológica,
PqEB, Av. W5 Norte, Brasília, DF, 70770-917, Brazil. 2Departamento of Celular
Biology, University of Brasília, Brasília, DF, 70910-900, Brazil. 3Institute for
Molecular Bioscience and School of Biomedical Sciences, University of
Queensland, St Lucia, Queensland, Australia. 4Blood Center of Ribeirão Preto,
Center of Celular Therapy - FMRP/USP, Rua Tenente Catão Roxo 2501, Monte
Alegre, Ribeirão Preto, SP, 14051-140, Brazil. 5Molecular Targets Development
Program, National Cancer Institute at Frederick, Frederick, MD 21702, USA.
6Ludwig Institute for Cancer Research Ltd, New York Branch of Human
Cancer Immunology at Memorial Sloan-Kettering Cancer Center 1275 York
Avenue, BOX 32, New York, NY, 10065, USA.
Published: 1 October 2014
References
1. Ma JK, Drake PM, Christou P: The Production of Recombinant
Pharmaceutical Proteins in Plants. Nature Reviews Genetics 2003, 4:794-805.
2. Ma JK, Christou P, Chikwamba R, Haydon H, Paul M, Pujol Ferrer M,
Ramalingam S, Rech E, Rybicki E, Wigdorowitz A, Yang D-C, Thangaraj H:
Realising the value of plant molecular pharming to benefit the poor in
developing countries and emerging economies. Plant Biotechnology
Journal 2013.
3. Rech EL, Lopes MR: Insights into Brazilian agricultural structure and
sustainable intensification of food production. Food and Energy Security
2012, 1:77-80.
4. Rech EL, Vianna GR, Aragão FJL: High-efficiency transformation by
biolistics of soybean common bean and cotton transgenic plants.
NATURE Protocols 2008, 3:410-418.
5. Rech EL: Seeds recombinant DNA and biodiversity. Seed Science Research
2012, 22:36-44.
6. Murad AM, Souza GHMF, Garcia JS, Rech EL: Detection and expression
analysis of recombinant proteins in plant complex mixtures using
nanoUPLC-MSE. Journal of Science Separation 2012, 34:2618-2630, 2012.
7. Gibson DG, Glass JI, Lartigue C, Noskov VN, Chuang R-Y, Algire MA,
Benders GA, Montague MG, Ma L, Moodie MM, Merryman C, Vashee S,
Krishnakumar R, Assad-Garcia N, Andrews-Pfannkoch C, Denisova EA,
Young L, Qi Z-Q, Seggall-Shapirro TH, Calvey CH, Parmar PP, Hutchison CA,
Smith HO, Venter JC: Creation of a Bacterial Cell Controlled by a
Chemically Synthesized Genome. Science 2010, 329:52-56.
8. Hockemeyer D, Wang H, Kiani S, Lai CS, Cassady JP, Cost GJ, Zhang L,
Santiago Y, Miller JC, Zeitler B, Cherone JM, Meng X, Hinkley SJ, Rebar EJ,
Gregory P, Urnov FD, Jaenish R: Genetic engineering of human pluripotent
cells using TALE nucleases. Nature Biotechnology 2011, 29:731-734.
9. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenich R:
One-Step Generation of Mice Carrying Mutations in Multiple Genes by
CRISPR/Cas-Mediated Genome Engineering. Cell 2013, 153:910-918.
10. Rech EL, Arber W: Biodiversity as a source for synthetic domestication of
useful specific traits. Annals of Applied Biology 2013, 162:141-144.
doi:10.1186/1753-6561-8-S4-O1
Cite this article as: Rech et al.: Recombinant proteins in plants. BMC
Proceedings 2014 8(Suppl 4):O1.
Rech et al. BMC Proceedings 2014, 8(Suppl 4):O1
http://www.biomedcentral.com/1753-6561/8/S4/O1
Page 2 of 2
